CliffBio
small molecule

NITYR

NITISINONE

Loss of exclusivityJanuary 2035latest FDA-listed patent expiry
CompanyCycle Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameNITYR
Active ingredientNITISINONE
Strength2MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2017
Marketing statusRX

Listed patents

PatentExpiresType
10328029January 2035product

More from Cycle Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

NITYR patent cliff — loss of exclusivity January 2035 | CliffBio